Hims & Hers Health Inc (NYSE: HIMS): Stock Performance & Trend Analysis

In today’s recent session, 1.98 million shares of the Hims & Hers Health Inc (NYSE:HIMS) have been traded, and its beta is 1.09. Most recently the company’s share price was $22.41, and it changed around $0.26 or 1.17% from the last close, which brings the market valuation of the company to $4.81B. HIMS at last check was trading at a discount to its 52-week high of $25.74, offering almost -14.86% off that amount. The share price’s 52-week low was $5.65, which indicates that the recent value has risen by an impressive 74.79% since then. We note from Hims & Hers Health Inc’s average daily trading volume that its 3-month average coming to 9.38 million.

Hims & Hers Health Inc (NYSE:HIMS) trade information

Instantly HIMS has been showing a green trend so far today with a performance of 1.17% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently up 151.80% year-to-date, but still down -5.64% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is 38.59% up in the 30-day period.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The consensus price target as assigned by Wall Street analysts is $13.29, which translates to bulls needing to decrease their stock price by -68.62% from its current value. Analyst projections state that HIMS is forecast to be at a low of $5 and a high of $24.

Hims & Hers Health Inc (HIMS) estimates and forecasts

Hims & Hers Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 168.71 percent over the past six months and at a 272.73% annual growth rate that is well above the industry average of 17.70%. The year-over-year growth rate is expected to be 39.70%, up from the previous year.

Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 297.41M in revenue for the current quarter. 12 analysts expect Hims & Hers Health Inc to make 317.46M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 204.96M and 226.7M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 45.10%. Forecasts for the next quarter put sales growth at 40.00%.

HIMS Dividends

Hims & Hers Health Inc’s next quarterly earnings report is expected to be released in July.